850 related articles for article (PubMed ID: 23999080)
1. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
[TBL] [Abstract][Full Text] [Related]
2. A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.
Maruyama T; Fujisawa T; Ishida T; Ito A; Oyamada Y; Fujimoto K; Yoshida M; Maeda H; Miyashita N; Nagai H; Imamura Y; Shime N; Suzuki S; Amishima M; Higa F; Kobayashi H; Suga S; Tsutsui K; Kohno S; Brito V; Niederman MS
Clin Infect Dis; 2019 Mar; 68(7):1080-1088. PubMed ID: 30084884
[TBL] [Abstract][Full Text] [Related]
3. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.
Falcone M; Venditti M; Shindo Y; Kollef MH
Int J Infect Dis; 2011 Aug; 15(8):e545-50. PubMed ID: 21616695
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
[TBL] [Abstract][Full Text] [Related]
5. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization.
Garcia-Vidal C; Viasus D; Roset A; Adamuz J; Verdaguer R; Dorca J; Gudiol F; Carratalà J
Clin Microbiol Infect; 2011 Nov; 17(11):1659-65. PubMed ID: 21463391
[TBL] [Abstract][Full Text] [Related]
7. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study.
Chalmers JD; Taylor JK; Singanayagam A; Fleming GB; Akram AR; Mandal P; Choudhury G; Hill AT
Clin Infect Dis; 2011 Jul; 53(2):107-13. PubMed ID: 21690616
[TBL] [Abstract][Full Text] [Related]
9. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
[TBL] [Abstract][Full Text] [Related]
11. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
Webb BJ; Dascomb K; Stenehjem E; Dean N
Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
[TBL] [Abstract][Full Text] [Related]
12. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
[TBL] [Abstract][Full Text] [Related]
13. Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients.
Park SC; Kim EY; Kang YA; Park MS; Kim YS; Kim SK; Chang J; Jung JY
Int J Tuberc Lung Dis; 2013 May; 17(5):704-9. PubMed ID: 23575340
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals.
Hoo Lee J; Hyung Kim Y
Braz J Infect Dis; 2012; 16(4):321-8. PubMed ID: 22846118
[TBL] [Abstract][Full Text] [Related]
15. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.
Wu CL; Ku SC; Yang KY; Fang WF; Tu CY; Chen CW; Hsu KH; Fan WC; Lin MC; Chen W; Ou CY; Yu CJ
J Formos Med Assoc; 2013 Jan; 112(1):31-40. PubMed ID: 23332427
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia.
Umeki K; Tokimatsu I; Yasuda C; Iwata A; Yoshioka D; Ishii H; Shirai R; Kishi K; Hiramatsu K; Matsumoto B; Kadota J
Respirology; 2011 Jul; 16(5):856-61. PubMed ID: 21545370
[TBL] [Abstract][Full Text] [Related]
19. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.
Aliberti S; Di Pasquale M; Zanaboni AM; Cosentini R; Brambilla AM; Seghezzi S; Tarsia P; Mantero M; Blasi F
Clin Infect Dis; 2012 Feb; 54(4):470-8. PubMed ID: 22109954
[TBL] [Abstract][Full Text] [Related]
20. Is the present definition of health care-associated pneumonia the best way to define risk of infection with antibiotic-resistant pathogens?
Yap V; Datta D; Metersky ML
Infect Dis Clin North Am; 2013 Mar; 27(1):1-18. PubMed ID: 23398862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
